Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Common Stock	Additional paid in capital	Accumulated Deficit	Accumulated other comprehensive income (loss)	Noncontrolling interest	Total
Balance at the beginning of period at Dec. 31, 2020		$ 1,818	$ (763)	$ (120)	$ 1	$ 936
Balance at the beginning of period (in shares) at Dec. 31, 2020	61.2
Increase (Decrease) in Shareholders' Equity
Common stock issuance, net of transaction fees		380				380
Common stock issuance, net of transaction fees (in shares)	10.0
Common stock issued under employee stock purchase plan		2				2
Common stock issued under employee stock purchase plan (in shares)	0.1
Equity classified stock-based compensation expense		7				7
Equity classified stock-based compensation expense (in shares)	0.4
Comprehensive income (loss)			(84)	6		(78)
Balance at the end of period at Mar. 31, 2021		2,207	(847)	(114)	1	1,247
Balance at the end of period (in shares) at Mar. 31, 2021	71.7
Balance at the beginning of period at Dec. 31, 2020		1,818	(763)	(120)	1	936
Balance at the beginning of period (in shares) at Dec. 31, 2020	61.2
Increase (Decrease) in Shareholders' Equity
Comprehensive income (loss)						(28)
Balance at the end of period at Jun. 30, 2021		2,211	(803)	(109)	1	1,300
Balance at the end of period (in shares) at Jun. 30, 2021	72.4
Balance at the beginning of period at Mar. 31, 2021		2,207	(847)	(114)	1	1,247
Balance at the beginning of period (in shares) at Mar. 31, 2021	71.7
Increase (Decrease) in Shareholders' Equity
Common stock issued under employee stock purchase plan		2				2
Common stock issued under employee stock purchase plan (in shares)	0.1
Equity classified stock-based compensation expense		2				2
Equity classified stock-based compensation expense (in shares)	0.6
Dividends			(1)			(1)
Comprehensive income (loss)			45	5		50
Balance at the end of period at Jun. 30, 2021		2,211	(803)	(109)	1	1,300
Balance at the end of period (in shares) at Jun. 30, 2021	72.4
Balance at the beginning of period at Dec. 31, 2021		2,235	(720)	(53)	1	$ 1,463
Balance at the beginning of period (in shares) at Dec. 31, 2021	72.7					72.7
Increase (Decrease) in Shareholders' Equity
Common stock issued under employee stock purchase plan		2				$ 2
Common stock issued under employee stock purchase plan (in shares)	0.1
Equity classified stock-based compensation expense		6				6
Equity classified stock-based compensation expense (in shares)	0.6
Comprehensive income (loss)			(7)	11		4
Balance at the end of period at Mar. 31, 2022		2,243	(727)	(42)	1	1,475
Balance at the end of period (in shares) at Mar. 31, 2022	73.4
Balance at the beginning of period at Dec. 31, 2021		2,235	(720)	(53)	1	$ 1,463
Balance at the beginning of period (in shares) at Dec. 31, 2021	72.7					72.7
Increase (Decrease) in Shareholders' Equity
Comprehensive income (loss)						$ (26)
Balance at the end of period at Jun. 30, 2022		2,246	(758)	(42)		$ 1,446
Balance at the end of period (in shares) at Jun. 30, 2022	74.2					74.2
Balance at the beginning of period at Mar. 31, 2022		2,243	(727)	(42)	1	$ 1,475
Balance at the beginning of period (in shares) at Mar. 31, 2022	73.4
Increase (Decrease) in Shareholders' Equity
Common stock issued under employee stock purchase plan		2				2
Common stock issued under employee stock purchase plan (in shares)	0.1
Equity classified stock-based compensation expense		1				1
Equity classified stock-based compensation expense (in shares)	0.7
Dividends			(1)			(1)
Comprehensive income (loss)			(30)			(30)
Other					$ (1)	(1)
Balance at the end of period at Jun. 30, 2022		$ 2,246	$ (758)	$ (42)		$ 1,446
Balance at the end of period (in shares) at Jun. 30, 2022	74.2					74.2